Fay Chinnery

Publications

16 publications

Page 1 of 2

Efgartigimod for treating generalised myasthenia gravis

Fay Chinnery, Lois Woods, Keith Cooper, Bogdan Grigore, David Alexander Scott & Joanna Picot, 2023

Type: report

Bimekizumab for treating active psoriatic arthritis

David Alexander Scott, Karen Pickett, Keith Cooper, Fay Chinnery & Joanna Picot, 2023

Type: report

Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer

Lorna Hazell, Keith Cooper, Fay Chinnery, Karen Pickett, David Alexander Scott & Jonathan Shepherd, 2023

Type: report

ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial

Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy, Fay Chinnery, Laura Day, Diana Fernando, Kirit Ardeshna, Graham Collins, John Radford, Simon Rule, Andrew Mcmillan, Peter Johnson & Gareth Griffiths, 2022, F1000Research, 9

DOI: 10.12688/f1000research.22318.1

Type: article

Nintedanib for treating idiopathic pulmonary fibrosis in people with a forced vital capacity above 80% predicted (part-review of technology appraisal guidance 379)

Keith Cooper, Lorna Hazell, Asyl Hawa, Joanna Picot, Fay Chinnery, David Alexander Scott & Jonathan Shepherd, 2022

Type: report

Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women

Susanne Renz, Fay Chinnery, Beth Stuart, Laura Day, Ingrid Muller, Irene Soulsby, Jacqui Nuttall, Karen Thomas, Kim Suzanne Thomas, Tracey Sach, Louise Stanton, Matthew J Ridd, Nick Francis, Paul Little, Zina Eminton, Gareth Griffiths, Alison M Layton & Miriam Santer, 2021, BMJ Open, 11(8)

DOI: 10.1136/bmjopen-2021-053876

Type: article

A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes

Andrew Davies, Christopher Mansbridge, Peter Simmonds, Nicholas Murray, Louise Stanton, Fay Chinnery, Caroline Archer, Peter Barrett-Lee, Tamas Hickish & Simon Crabb, 2020, F1000 Research

Type: article

Evaluation of stakeholder views on peer review of NIHR applications for funding

Sheila Turner, Abby Bull, Fay Chinnery, Jeremy Hinks, Nicola McArdle, Rebecca Moran, Helen Payne, Eleanor Woodford Guegan, Louise Worswick & Jeremy C. Wyatt, 2018, BMJ Open, 8(12)

DOI: 10.1136/bmjopen-2018-022548

Type: article

Ensuring value in health-related research

Fay Chinnery, Kelly M. Dunham, Barbara van der Linden, Matthew Westmore & Evelyn Whitlock, 2018, The Lancet, 391(10123), 836-837

DOI: 10.1016/S0140-6736(18)30464-1

Type: article

National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease

Fay Chinnery, Gemma Bashevoy, Amanda Blatch-Jones, Lisa Douet, Sarah Puddicombe & James Raftery, 2018, Trials, 19(1)

DOI: 10.1186/s13063-018-2489-7

Type: article

Dr Fay Chinnery

Connect with Fay

Publications

Biography